ＪＣＲファーマ（4552）　Sumitomo Dainippon Pharma and JCR Sign a License Agreement on Blood-Brain Barrier Penetration Technology for Creation of a Therapeutic Agent for Centr 2018/02/26
/-
読み込み中…